Comparative performance of the Geenius™ HIV-1/HIV-2 supplemental test in Florida's public health testing population.

Abstract

BACKGROUND The Centers for Disease Control and Prevention (CDC) published updated guidelines in 2014 for the laboratory diagnosis of HIV in the United States, which recommend use of a supplemental immunoassay (IA) that differentiates HIV-1 from HIV-2 after a repeatedly reactive HIV-1/2 antigen/antibody "Combo" screening test. In October 2014, Bio-Rad… (More)
DOI: 10.1016/j.jcv.2017.04.005

Topics

Cite this paper

@article{Fordan2017ComparativePO, title={Comparative performance of the Geenius™ HIV-1/HIV-2 supplemental test in Florida's public health testing population.}, author={Sally Fordan and Berry Bennett and Meghan Lee and Susanne N Crowe}, journal={Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology}, year={2017}, volume={91}, pages={79-83} }